Virtu Financial’s Caribou Biosciences CRBU Stock Holding History

Virtu Financial’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80K	Buy	45,188 +8,579	+23%	+$17K	﹤0.01%	1147
2026 Q1	$70K	Buy	+36,609	New	+$62.8K	﹤0.01%	1235
2024 Q2	–	Sell	-82,100	Closed	-$422K	–	1397
2024 Q1	$422K	Buy	82,100 +65,542	+396%	+$404K	0.03%	475
2023 Q4	$95K	Sell	16,558 -16,491	-50%	-$81.5K	0.01%	1038
2023 Q3	$158K	Buy	+33,049	New	+$205K	0.02%	722
2022 Q4	–	Sell	-20,067	Closed	-$212K	–	1701
2022 Q3	$212K	Buy	20,067 +1,372	+7%	+$12.8K	0.02%	833
2022 Q2	$102K	Buy	+18,695	New	+$143K	0.01%	947
2021 Q4	–	Sell	-13,020	Closed	-$311K	–	1784
2021 Q3	$311K	Buy	+13,020	New	+$318K	0.03%	698

Other funds holding CRBU

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Virtu Financial's CRBU Position: Q2 2026 in Review

Virtu Financial increased its Caribou Biosciences (CRBU) stake by 23% in Q2 2026, buying an estimated $17K and bringing the position to 45,188 shares worth $80K. The position accounts for ﹤0.01% of the portfolio, ranked #1147.

Virtu Financial first reported a position in CRBU in Q3 2021 and has held it in 8 quarters since. The position peaked at $422K in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Virtu Financial held 45,188 shares of Caribou Biosciences worth $80K as of Q2 2026.
Virtu Financial bought 8,579 Caribou Biosciences shares in Q2 2026, an estimated $17K.
Caribou Biosciences made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1147 holding.
Virtu Financial first reported a position in Caribou Biosciences in Q3 2021 and has held it in 8 quarters since.
Virtu Financial's Caribou Biosciences position peaked at $422K in Q1 2024.
137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.